Company page
Anavex Life Sciences Corp.
Anavex Life Sciences Corp. is a public company traded under the ticker AVXL in the American market. The company has a market capitalization of approximately $253 million. Anavex focuses on developing therapies for neurodegenerative diseases, aiming to improve the quality of life for patients.
- Ticker
- AVXL:NASDAQ
- Asset type
- Stock
- Market cap
- $253.0M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD